6ZBA

Crystal structure of PDE4D2 in complex with inhibitor LEO39652


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.60 Å
  • R-Value Free: 0.192 
  • R-Value Work: 0.162 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history


Literature

Discovery and Early Clinical Development of Isobutyl 1-[8-Methoxy-5-(1-oxo-3 H -isobenzofuran-5-yl)-[1,2,4]triazolo[1,5- a ]pyridin-2-yl]cyclopropanecarboxylate (LEO 39652), a Novel "Dual-Soft" PDE4 Inhibitor for Topical Treatment of Atopic Dermatitis.

Larsen, J.Lambert, M.Pettersson, H.Vifian, T.Larsen, M.Ollerstam, A.Hegardt, P.Eskilsson, C.Laursen, S.Soehoel, A.Skak-Nielsen, T.Hansen, L.M.Knudsen, N.O.Eirefelt, S.Sorensen, M.D.Stilou, T.G.Nielsen, S.F.

(2020) J Med Chem 63: 14502-14521

  • DOI: https://doi.org/10.1021/acs.jmedchem.0c00797
  • Primary Citation of Related Structures:  
    6ZBA

  • PubMed Abstract: 

    We describe the design of a novel PDE4 scaffold and the exploration of the dual-soft concept to reduce systemic side effects via rapid elimination: introducing ester functionalities that can be inactivated in blood as well as by the liver (dual-soft) while being stable in human skin. Compound 40 was selected as a clinical candidate as it was potent and rapidly degraded by blood and liver to inactive metabolites and because in preclinical studies it showed high exposure at the target organ: the skin. Preclinical and clinical data are presented confirming the value of the dual-soft concept in reducing systemic exposure.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
cAMP-specific 3',5'-cyclic phosphodiesterase 4DA [auth AAA],
B [auth BBB],
C [auth CCC],
D [auth DDD]
360Homo sapiensMutation(s): 0 
Gene Names: PDE4DDPDE3
EC: 3.1.4.53
UniProt & NIH Common Fund Data Resources
Find proteins for Q08499 (Homo sapiens)
Explore Q08499 
Go to UniProtKB:  Q08499
PHAROS:  Q08499
GTEx:  ENSG00000113448 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ08499
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 5 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
QDT (Subject of Investigation/LOI)
Query on QDT

Download Ideal Coordinates CCD File 
AA [auth CCC],
E [auth AAA],
MA [auth DDD],
S [auth BBB]
2-methylpropyl 1-[8-methoxy-5-(1-oxidanylidene-3~{H}-2-benzofuran-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxylate
C23 H23 N3 O5
LUUUHUYQTLUIDG-UHFFFAOYSA-N
DMS
Query on DMS

Download Ideal Coordinates CCD File 
JA [auth CCC],
P [auth AAA],
TA [auth DDD],
X [auth BBB]
DIMETHYL SULFOXIDE
C2 H6 O S
IAZDPXIOMUYVGZ-UHFFFAOYSA-N
ZN
Query on ZN

Download Ideal Coordinates CCD File 
LA [auth CCC],
R [auth AAA],
VA [auth DDD],
Z [auth BBB]
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
EDO
Query on EDO

Download Ideal Coordinates CCD File 
BA [auth CCC]
CA [auth CCC]
DA [auth CCC]
EA [auth CCC]
F [auth AAA]
BA [auth CCC],
CA [auth CCC],
DA [auth CCC],
EA [auth CCC],
F [auth AAA],
FA [auth CCC],
G [auth AAA],
GA [auth CCC],
H [auth AAA],
HA [auth CCC],
I [auth AAA],
IA [auth CCC],
J [auth AAA],
K [auth AAA],
L [auth AAA],
M [auth AAA],
N [auth AAA],
NA [auth DDD],
O [auth AAA],
OA [auth DDD],
PA [auth DDD],
QA [auth DDD],
RA [auth DDD],
SA [auth DDD],
T [auth BBB],
U [auth BBB],
V [auth BBB],
W [auth BBB]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
MG
Query on MG

Download Ideal Coordinates CCD File 
KA [auth CCC],
Q [auth AAA],
UA [auth DDD],
Y [auth BBB]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.60 Å
  • R-Value Free: 0.192 
  • R-Value Work: 0.162 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 100.03α = 90
b = 111.866β = 90
c = 159.623γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
Aimlessdata scaling
REFMACphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2020-09-23
    Type: Initial release
  • Version 1.1: 2020-10-28
    Changes: Database references
  • Version 1.2: 2020-12-23
    Changes: Database references
  • Version 1.3: 2024-01-24
    Changes: Data collection, Database references, Derived calculations, Refinement description